| Primary |
| Contraception |
65.8% |
| Off Label Use |
6.0% |
| Menstrual Discomfort |
3.9% |
| Endometriosis |
2.7% |
| Ill-defined Disorder |
2.5% |
| Depression |
2.5% |
| Menorrhagia |
2.4% |
| Hypertension |
1.8% |
| Asthma |
1.7% |
| Uterine Leiomyoma |
1.5% |
| Osteoarthritis |
1.2% |
| Dysmenorrhoea |
1.1% |
| Migraine |
1.1% |
| Anxiety |
1.0% |
| Diabetes Mellitus |
1.0% |
| Hormone Replacement Therapy |
0.9% |
| Back Pain |
0.8% |
| Menopausal Symptoms |
0.8% |
| Blood Cholesterol Increased |
0.6% |
| Hypersensitivity |
0.6% |
|
| Unintended Pregnancy |
18.7% |
| Osteoporosis |
17.7% |
| Weight Increased |
15.8% |
| Menorrhagia |
5.0% |
| Amenorrhoea |
4.9% |
| Metrorrhagia |
4.9% |
| Bone Density Decreased |
4.0% |
| Osteopenia |
3.6% |
| Urticaria |
2.9% |
| Weight Decreased |
2.8% |
| Pregnancy With Injectable Contraceptive |
2.8% |
| Vomiting |
2.7% |
| Drug Ineffective |
2.2% |
| Vaginal Haemorrhage |
2.1% |
| Haemorrhage |
2.0% |
| Rash |
1.7% |
| Injection Site Pain |
1.7% |
| Pulmonary Embolism |
1.6% |
| Osteoporotic Fracture |
1.5% |
| Alopecia |
1.5% |
|
| Secondary |
| Contraception |
28.1% |
| Off Label Use |
12.4% |
| Hormone Replacement Therapy |
7.8% |
| Menstrual Discomfort |
7.4% |
| Drug Use For Unknown Indication |
4.4% |
| Acarodermatitis |
3.9% |
| Depression |
3.9% |
| Endometriosis |
3.8% |
| Hypertension |
3.1% |
| Menorrhagia |
3.0% |
| Menopause |
2.8% |
| Menopausal Symptoms |
2.7% |
| Asthma |
2.6% |
| Product Used For Unknown Indication |
2.6% |
| Uterine Leiomyoma |
2.5% |
| Blood Cholesterol Increased |
2.0% |
| Diabetes Mellitus |
1.8% |
| Dysmenorrhoea |
1.8% |
| Migraine |
1.6% |
| Osteoarthritis |
1.6% |
|
| Unintended Pregnancy |
23.2% |
| Weight Increased |
22.4% |
| Amenorrhoea |
5.9% |
| Pregnancy With Injectable Contraceptive |
5.7% |
| Weight Decreased |
3.8% |
| Breast Cancer |
3.5% |
| Osteoporosis |
3.5% |
| Metrorrhagia |
3.2% |
| Vomiting |
3.2% |
| Menorrhagia |
3.0% |
| Drug Ineffective For Unapproved Indication |
2.7% |
| No Adverse Event |
2.7% |
| Vaginal Haemorrhage |
2.7% |
| Breast Cancer Female |
2.4% |
| Hot Flush |
2.4% |
| Headache |
2.2% |
| Dysmenorrhoea |
1.9% |
| Feeling Abnormal |
1.9% |
| Pancreatitis |
1.9% |
| Urinary Tract Infection |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.2% |
| Contraception |
18.5% |
| Pain |
7.3% |
| Depression |
6.0% |
| Hiv Infection |
5.5% |
| Anxiety |
4.3% |
| Crohn's Disease |
4.2% |
| Drug Use For Unknown Indication |
3.7% |
| Acne |
3.6% |
| Smoking Cessation Therapy |
3.0% |
| Asthma |
3.0% |
| Hypertension |
2.8% |
| Headache |
2.5% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Insomnia |
2.1% |
| Multiple Sclerosis |
2.1% |
| Bipolar Disorder |
2.0% |
| Endometriosis |
1.7% |
| Rheumatoid Arthritis |
1.6% |
| Schizophrenia |
1.6% |
|
| Vomiting |
11.2% |
| Weight Increased |
10.9% |
| Nausea |
7.0% |
| Pain |
6.1% |
| Pulmonary Embolism |
6.1% |
| Suicide Attempt |
6.1% |
| White Blood Cell Count Increased |
6.1% |
| Weight Decreased |
5.9% |
| Vaginal Haemorrhage |
4.5% |
| Drug Ineffective |
3.9% |
| Deep Vein Thrombosis |
3.6% |
| Treatment Noncompliance |
3.6% |
| Vision Blurred |
3.6% |
| Cholecystitis Chronic |
3.4% |
| Suicidal Ideation |
3.4% |
| Type 2 Diabetes Mellitus |
3.4% |
| Rectal Haemorrhage |
3.1% |
| Tremor |
3.1% |
| Abdominal Pain Upper |
2.5% |
| White Blood Cell Count Decreased |
2.5% |
|
| Interacting |
| Drug Use For Unknown Indication |
27.9% |
| Contraception |
23.3% |
| Onychomycosis |
14.0% |
| Product Used For Unknown Indication |
11.6% |
| Attention Deficit/hyperactivity Disorder |
4.7% |
| Blood Pressure |
4.7% |
| Migraine Prophylaxis |
4.7% |
| Antibiotic Prophylaxis |
2.3% |
| Crohn's Disease |
2.3% |
| Menstruation Irregular |
2.3% |
| Schizophrenia, Disorganised Type |
2.3% |
|
| Metrorrhagia |
42.9% |
| Necrobiosis |
14.3% |
| Restlessness |
14.3% |
| Diarrhoea |
7.1% |
| Drug Interaction |
7.1% |
| Pregnancy With Injectable Contraceptive |
7.1% |
| Thrombophlebitis |
7.1% |
|
